Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of dl-3-n-butylphthalide in traumatic brain injury
ChiCTR1900022798Phase 4Recruiting
- Sponsor
- Changzhou Wujin People's Hospital
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of butylphthalide in traumatic brain injury (TBI) (2 arms), sponsored by Changzhou Wujin People's Hospital. Primary endpoints: Cerebral blood volume, Cerebral blood flow and 8 more. Started May 2019; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR1900022798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022798.